+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Thyroid Cancer Diagnostics Market - Global Forecast 2026-2032- Product Image
Thyroid Cancer Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Thyroid Cancer Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5533182
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The thyroid cancer diagnostics market is undergoing significant transformation as molecular assays and clinical advances raise diagnostic precision. Senior executives in healthcare and diagnostics must navigate clinical, operational, and strategic challenges as new technologies reshape workflows and supply chains.

Market Snapshot: Thyroid Cancer Diagnostics Market Growth

The global thyroid cancer diagnostics market expanded from USD 270.14 million in 2025 to USD 289.98 million in 2026, with projections to reach USD 407.84 million by 2032 at a compound annual growth rate (CAGR) of 6.06%. This upward momentum reflects expanding adoption of molecular techniques and increasing demand for precise cancer diagnostics across diverse care settings and geographies.

Scope & Segmentation

  • Diagnostic Technologies: The market covers immunoassays—including chemiluminescence immunoassay and ELISA—alongside immunohistochemistry, next generation sequencing, real time PCR using digital and quantitative approaches, and advanced protein testing for improved detection and risk assessment.
  • Biomarker Categories: Diagnostic tests utilize epigenetic markers such as DNA methylation and miRNA, genetic markers including BRAF, RAS, and TERT, and protein markers like thyroglobulin and calcitonin, providing comprehensive and multi-layered diagnostic options.
  • Sample Types: Blood, fine needle aspiration, and tissue biopsy are commonly applied, with growing emphasis on minimally invasive and liquid-based sampling for streamlined procedures and enhanced patient comfort.
  • Applications: Diagnostic products address initial cancer detection, enable risk stratification, support monitoring for recurrence, and facilitate therapy monitoring, serving stakeholders throughout the patient care continuum.
  • End Users: The landscape comprises academic research institutes—including cancer research centers and university laboratories—ambulatory care and imaging centers, specialized clinics, diagnostic laboratory chains and independents, as well as both private and public hospitals.
  • Geographies: The market spans the Americas, EMEA (covering Europe, Middle East, and Africa), and Asia-Pacific. Each geography faces unique regulatory requirements and reimbursement considerations, influencing technology adoption and market entry strategies.

Key Takeaways

  • Integration of molecular, histopathological, and protein-based diagnostic workflows reduces indeterminate results, improving clarity in thyroid cancer management and helping organizations deliver more precise patient pathways.
  • Cross-disciplinary collaboration and investment in workflow automation and personnel training allow health systems to transition efficiently from traditional morphology-based approaches to advanced, multi-platform protocols.
  • Innovations in liquid-based sample handling promote adoption of less invasive diagnostics, increasing laboratory efficiency and improving patient experience by minimizing procedural discomfort.
  • The competitive environment is constantly evolving, as established companies, agile start-ups, and strategic alliances deliver differentiated solutions and expedite guideline adoption in varied markets.
  • Diagnostic companies are increasing the use of digital data tools, such as cloud-based platforms and telepathology, to strengthen evidence generation and support consistent decision-making in clinical settings.

Tariff Impact on Thyroid Cancer Diagnostics Market

Tariff policies are influencing costs across instruments, reagents, and consumables, affecting manufacturers and healthcare providers worldwide. Organizations are addressing these drivers by exploring local suppliers, negotiating longer-term contracts, and fostering regional production partnerships to mitigate procurement risks. Laboratories increasingly consolidate diagnostic platforms and adopt workflow automation to improve operational agility. Demonstrating clinical and economic value is critical for maintaining support among payers and procurement agencies. Global tariff trends emphasize the importance of supply chain resilience and localized go-to-market strategies to adapt to fluctuating regulatory environments.

Methodology & Data Sources

This analysis is based on direct interviews with clinicians, laboratory leaders, and industry experts, combined with a systematic review of peer-reviewed literature, regulatory filings, and technical documents. Laboratory performance data and biomarker validation studies inform the relevance and accuracy of all findings.

Why This Report Matters

  • Delivers actionable insights for senior leaders regarding technology investment, procurement strategy, and market entry in a rapidly evolving segment of cancer diagnostics.
  • Supports informed decision-making tied to supply chain resilience and regional commercialization strategies amid shifting reimbursement, regulatory, and adoption landscapes.
  • Guides evidence development and partnership models that are essential to achieve regulatory alignment and payer engagement within the thyroid cancer diagnostics sector.

Conclusion

Thyroid cancer diagnostics are becoming more precise through technological integration and clinical innovation. Success in this market will depend on fostering resilience, validation, and tailored commercialization. Strategic partnerships will be essential in translating advancements into improved patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Thyroid Cancer Diagnostics Market, by Technology
8.1. Immunoassay
8.1.1. Chemiluminescence Immunoassay
8.1.2. ELISA
8.2. Immunohistochemistry
8.3. Next Generation Sequencing
8.3.1. Targeted Sequencing
8.3.2. Whole Exome Sequencing
8.3.3. Whole Genome Sequencing
8.4. Real Time PCR
8.4.1. Digital PCR
8.4.2. qPCR
9. Thyroid Cancer Diagnostics Market, by Sample Type
9.1. Blood Sample
9.2. Fine Needle Aspiration
9.3. Tissue Biopsy
10. Thyroid Cancer Diagnostics Market, by Biomarker Type
10.1. Epigenetic Markers
10.1.1. DNA Methylation
10.1.2. miRNA
10.2. Genetic Markers
10.2.1. BRAF
10.2.2. RAS
10.2.3. TERT
10.3. Protein Markers
10.3.1. Calcitonin
10.3.2. Thyroglobulin
11. Thyroid Cancer Diagnostics Market, by Application
11.1. Diagnosis
11.2. Prognosis
11.3. Recurrence Monitoring
11.4. Therapy Monitoring
12. Thyroid Cancer Diagnostics Market, by End User
12.1. Academic Research Institutes
12.1.1. Cancer Research Centers
12.1.2. University Laboratories
12.2. Ambulatory Care Centers
12.2.1. Imaging Centers
12.2.2. Specialized Clinics
12.3. Diagnostic Laboratories
12.3.1. Chain Laboratories
12.3.2. Independent Laboratories
12.4. Hospitals
12.4.1. Private Hospitals
12.4.2. Public Hospitals
13. Thyroid Cancer Diagnostics Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Thyroid Cancer Diagnostics Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Thyroid Cancer Diagnostics Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Thyroid Cancer Diagnostics Market
17. China Thyroid Cancer Diagnostics Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Agilent Technologies, Inc.
18.7. Becton, Dickinson & Company
18.8. bioMérieux S.A.
18.9. Bio-Rad Laboratories, Inc.
18.10. Danaher Corporation
18.11. DIASORIN S.p.A
18.12. Exact Sciences Corporation
18.13. F. Hoffmann-La Roche AG
18.14. FONAR Corporation
18.15. Fulgent Genetics, Inc.
18.16. GE HealthCare
18.17. Guardant Health, Inc.
18.18. Hologic, Inc.
18.19. Illumina Inc.
18.20. Interpace Diagnostics
18.21. Koninklijke Philips N.V.
18.22. Merck KGaA
18.23. Myriad Genetics, Inc.
18.24. PerkinElmer, Inc.
18.25. QIAGEN N.V.
18.26. Siemens Healthineers AG
18.27. Sysmex Corporation
18.28. Thermo Fisher Scientific Inc.
18.29. Thyrocare Technologies Ltd.
18.30. Toshiba Corporation
18.31. Veracyte, Inc.
List of Figures
FIGURE 1. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL THYROID CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA THYROID CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY QPCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD SAMPLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD SAMPLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DNA METHYLATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DNA METHYLATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY MIRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY MIRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY MIRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BRAF, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BRAF, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BRAF, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TERT, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TERT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TERT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CALCITONIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CALCITONIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CALCITONIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY THYROGLOBULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY THYROGLOBULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY THYROGLOBULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RECURRENCE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RECURRENCE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY THERAPY MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY THERAPY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY THERAPY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CHAIN LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CHAIN LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CHAIN LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 202. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 204. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 205. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 206. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2032 (USD MILLION)
TABLE 207. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 208. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 209. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 210. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 211. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2032 (USD MILLION)
TABLE 212. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 215. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
TABLE 216. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 217. EUROPE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 234. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 237. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 238. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2032 (USD MILLION)
TABLE 239. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 240. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 241. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 242. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 243. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2032 (USD MILLION)
TABLE 244. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 245. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 247. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
TABLE 248. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 249. AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 257. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 258. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 263. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
TABLE 264. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 265. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 266. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 267. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 269. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 270. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 271. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2032 (USD MILLION)
TABLE 272. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 273. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 274. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 275. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 276. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2032 (USD MILLION)
TABLE 277. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 278. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 280. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
TABLE 281. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 282. ASEAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 283. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 284. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 285. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 286. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 287. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, 2018-2032 (USD MILLION)
TABLE 288. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 289. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 290. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 291. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC MARKERS, 2018-2032 (USD MILLION)
TABLE 292. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MARKERS, 2018-2032 (USD MILLION)
TABLE 293. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 294. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 295. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 296. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
TABLE 297. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 298. GCC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION THYROID CANCER DIAGNOS

Companies Mentioned

The key companies profiled in this Thyroid Cancer Diagnostics market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • bioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DIASORIN S.p.A
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche AG
  • FONAR Corporation
  • Fulgent Genetics, Inc.
  • GE HealthCare
  • Guardant Health, Inc.
  • Hologic, Inc.
  • Illumina Inc.
  • Interpace Diagnostics
  • Koninklijke Philips N.V.
  • Merck KGaA
  • Myriad Genetics, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Thyrocare Technologies Ltd.
  • Toshiba Corporation
  • Veracyte, Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 289.98 Million
Forecasted Market Value ( USD ) by 2032 $ 407.84 Million
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Head & Neck Cancer Diagnostics Market - Global Forecast 2026-2032 - Product Image

Head & Neck Cancer Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Thyroid Cancer Diagnostics Market - Global Strategic Business Report - Product Image

Thyroid Cancer Diagnostics Market - Global Strategic Business Report

  • Report
  • 374 Pages
  • Global
From
Cancer Diagnostics Market - Technologies, Applications and End-Use Facilities - Product Image

Cancer Diagnostics Market - Technologies, Applications and End-Use Facilities

  • Report
  • 278 Pages
  • Global
From
Thyroid Cancer Diagnostics Market Report 2025 - Product Image

Thyroid Cancer Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Thyroid Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Thyroid Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.